Jeon, Youngbae https://orcid.org/0000-0003-1322-9536
Jung, MinJeong
Jeong, BongHwang
Lee, Haejun
Sym, Sun Jin
Baek, Jeong-Heum https://orcid.org/0000-0001-9124-8041
Funding for this research was provided by:
MetiMedi Pharmacueticals
Article History
Received: 10 July 2024
Accepted: 19 May 2025
First Online: 25 May 2025
Declarations
:
: This study was approved by the Institutional Review Board of the Gachon University Gil Medical Center (authorization number: GCIRB2017-246) and the Ministry of Food and Drug Safety. This study was conducted following the principles of the Declaration of Helsinki. The clinical trial was monitored by an independent Contract Research Organization of LSK Global Pharma Services Co., Ltd. All patients signed a written informed consent form after being advised of the risks, benefits, and alternatives to the study treatments.
: Not applicable.
: The authors declare that this study was supported by Metimeti Pharmaceuticals, which provided both the investigational product (OMT-110) and funding.